Product Details
Melanotan II is a synthetic peptide classified as an analog of alpha-melanocyte-stimulating hormone (α–MSH), a peptide involved in melanocortin receptor-associated signaling pathways in biochemical research.
Within laboratory settings, Melanotan II is examined for its interaction with melanocortin receptors and its role in modulating signaling cascades associated with pigment-related molecular pathways. Its peptide structure enables it to participate in receptor-binding studies and intracellular signaling investigations.
This compound is supplied strictly for in vitro research applications and is not intended for use in living systems.
Mechanism of Action
Melanotan II is characterized in research as a melanocortin receptor agonist, interacting primarily with melanocortin receptor subtypes involved in intracellular signaling pathways.
At the molecular level, it is studied for its binding affinity to melanocortin receptors (MC1R, MC3R, MC4R, and MC5R), where it participates in receptor-mediated signaling cascades. These interactions are associated with cyclic adenosine monophosphate (cAMP) pathway activation and downstream signaling processes.
Ligand-Receptor Binding→cAMP Activation→Signal Transductiontext{Ligand-Receptor Binding} rightarrow text{cAMP Activation} rightarrow text{Signal Transduction}Ligand-Receptor Binding→cAMP Activation→Signal Transduction
Additionally, Melanotan II is utilized in experimental models to study receptor-ligand dynamics, signal amplification mechanisms, and peptide-receptor interaction profiles within melanocortin systems.
Chemical Properties of Melanotan II
| Property | Value |
| Compound Name | Melanotan II |
| Classification | Synthetic Peptide |
| Molecular Formula | C50H69N15O9 |
| Molecular Weight | 1024.2 g/mol |
| CAS Number | 121062-08-6 |
| PubChem CID | 92432 |
| Synonyms | Melanotan II, Melanotan-II, Melanotan (MT)-II, CHEMBL430239, UPF5CJ93X7 |
| IUPAC Name | (3S,6S,9R,12S,15S,23S)-15-[[(2S)-2-acetamidohexanoyl]amino]-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexazacyclotricosane-23-carboxamide |
| Shelf Life | 36 months |
Research Applications
Melanocortin Receptor Binding Studies
Melanotan II is widely utilized in receptor-binding assays focusing on melanocortin receptor subtypes. These studies investigate ligand affinity, receptor selectivity, and interaction kinetics within controlled experimental systems.
Intracellular Signaling Pathways
This peptide is examined in research exploring signaling cascades associated with cAMP activation and downstream molecular events linked to melanocortin receptor engagement.
Peptide-Receptor Interaction Modeling
Melanotan II is used in biochemical investigations to analyze peptide structure-function relationships, receptor activation mechanisms, and ligand-induced conformational changes.
Why Choose BehemothLabz to Buy Melanotan II for Research
BehemothLabz provides research-grade Melanotan II manufactured under controlled laboratory conditions with strict quality assurance protocols. Each batch undergoes analytical verification to ensure consistency in molecular composition and purity.
Comprehensive documentation, including laboratory testing reports and sourcing transparency, supports reproducibility in experimental settings. BehemothLabz maintains a compliance-focused approach, supplying compounds intended strictly for laboratory-based investigation and analytical research
Disclaimer
Melanotan II is intended strictly for laboratory research and analytical purposes only. It is not intended for use in diagnostic procedures, therapeutic applications, or in vivo studies of any kind.
Any references to biochemical pathways, receptor interactions, or enzymatic processes are provided solely for informational and research-context purposes. This compound must be handled exclusively by qualified professionals in controlled laboratory environments in accordance with applicable regulations and safety guidelines.
Improper handling or use outside of controlled research settings is strictly prohibited.
References
- Peters, B., Hadimeri, H., Wahlberg, R., & Afghahi, H. (2020). Melanotan II: a possible cause of renal infarction: review of the literature and case report. CEN case reports, 9(2), 159–161. https://doi.org/10.1007/s13730-020-00447-z
- Tomassi, S., Dimmito, M. P., Cai, M., D’Aniello, A., Del Bene, A., Messere, A., Liu, Z., Zhu, T., Hruby, V. J., Stefanucci, A., Cosconati, S., Mollica, A., & Di Maro, S. (2022). CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists. Journal of medicinal chemistry, 65(5), 4007–4017. https://doi.org/10.1021/acs.jmedchem.1c01848
